One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
An ‘Extraordinarily Generous’ Israeli Cease-Fire Offer With No Details
-
Secretary of State Antony Blinken calls Israel's latest offer to Hamas
“extraordinarily generous on the part of Israel.” Firm details are
nonexistent.
1 hour ago
No comments:
Post a Comment